Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges
Materials & Design · 2025-08 · 256 · 114243
DOI: 10.1016/j.matdes.2025.114243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials & Design, 2025-08. Verfasst von Kai Deng und 6 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Weifang Science and Technology Development Plan.
Abstract (Originalsprache)
Cardiovascular and cerebrovascular diseases represent leading global health challenges, accounting for approximately one-third of worldwide mortality, yet current therapeutic approaches remain inadequate due to complex etiology and limited drug delivery efficiency. This review examines engineered exosome technologies through analysis of preparation methodologies, biological characteristics, therapeutic applications, and clinical translation challenges. The review evaluates engineering approaches including viral/plasmid transfection, CRISPR/Cas9 genome editing, and post-isolation modifications such as electroporation, ultrasonication, and surface functionalization. Engineered exosomes demonstrate superior advantages over conventional synthetic systems through natural biocompatibility, enhanced circulation stability, blood–brain barrier penetration, reduced immunogenicity, and precise cellular targeting via receptor-mediated interactions. Key findings reveal successful therapeutic applications across atherosclerosis, myocardial infarction, heart failure, pulmonary arterial hypertension, stroke, intracerebral hemorrhage, and neurodegenerative conditions, effectively delivering diverse payloads including small molecules, proteins, nucleic acids, and diagnostic probes. Critical challenges requiring resolution include standardization of preparation protocols, scalable production methodologies, comprehensive pharmacokinetic characterization, preservation technologies, and rigorous safety evaluation frameworks. Through continued technological advancement, engineered exosomes present transformative opportunities for precision medicine approaches to cardiovascular and cerebrovascular disorders, establishing revolutionary nanoscale delivery platforms that address synthetic nanomaterial limitations.
Förderung
- the Weifang Science and Technology Development Plan
Zitieren
APA
Deng, K., Chen, Z., Zhang, X., Li, Y., Cheng, F., Wang, Z., & Wang, C. (2025). Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges. Materials & Design, 256, 114243. https://doi.org/10.1016/j.matdes.2025.114243
Vancouver
Deng K, Chen Z, Zhang X, Li Y, Cheng F, Wang Z, et al. Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges. Materials & Design. 2025;256:114243. doi:10.1016/j.matdes.2025.114243
BibTeX
@article{Deng2025,
author = {Deng, Kai and Chen, Zhen and Zhang, Xinyu and Li, Yueyuan and Cheng, Fangyu and Wang, Zengwu and Wang, Chunping},
title = {Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges},
journal = {Materials & Design},
year = {2025},
volume = {256},
pages = {114243},
doi = {10.1016/j.matdes.2025.114243}
}
EUVIMED